These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 22844557)

  • 1. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome.
    Martínez C; González-Castro A; Vicario M; Santos J
    Gut Liver; 2012 Jul; 6(3):305-15. PubMed ID: 22844557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome.
    Barbaro MR; Cremon C; Marasco G; Savarino E; Guglielmetti S; Bonomini F; Palombo M; Fuschi D; Rotondo L; Mantegazza G; Duncan R; di Sabatino A; Valente S; Pasquinelli G; Vergnolle N; Stanghellini V; Collins SM; Barbara G
    Gastroenterology; 2024 Nov; 167(6):1152-1166. PubMed ID: 39004156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.
    González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M
    J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.
    Pardo-Camacho C; Ganda Mall JP; Martínez C; Pigrau M; Expósito E; Albert-Bayo M; Melón-Ardanaz E; Nieto A; Rodiño-Janeiro B; Fortea M; Guagnozzi D; Rodriguez-Urrutia A; Torres I; Santos-Briones I; Azpiroz F; Lobo B; Alonso-Cotoner C; Santos J; González-Castro AM; Vicario M
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome
    Li X; Liu Q; Yu J; Zhang R; Sun T; Jiang W; Hu N; Yang P; Luo L; Ren J; Wang Q; Wang Y; Yang Q
    Food Funct; 2021 May; 12(9):4142-4151. PubMed ID: 33977961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.
    Ohman L; Simrén M
    Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):163-73. PubMed ID: 20101257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome.
    O'Malley D
    Exp Physiol; 2019 Jan; 104(1):3-10. PubMed ID: 30444291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Mast Cells in Irritable Bowel Syndrome.
    Lee KN; Lee OY
    Gastroenterol Res Pract; 2016; 2016():2031480. PubMed ID: 28115927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
    Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
    Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Barrier Function in Gastrointestinal Disorders.
    Farré R; Vicario M
    Handb Exp Pharmacol; 2017; 239():193-217. PubMed ID: 27995392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
    Barbara G
    Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune system in irritable bowel syndrome.
    Barbara G; Cremon C; Carini G; Bellacosa L; Zecchi L; De Giorgio R; Corinaldesi R; Stanghellini V
    J Neurogastroenterol Motil; 2011 Oct; 17(4):349-59. PubMed ID: 22148103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal barrier function in health and gastrointestinal disease.
    Camilleri M; Madsen K; Spiller R; Greenwood-Van Meerveld B; Verne GN
    Neurogastroenterol Motil; 2012 Jun; 24(6):503-12. PubMed ID: 22583600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside.
    Zhang L; Song J; Hou X
    J Neurogastroenterol Motil; 2016 Apr; 22(2):181-92. PubMed ID: 26755686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review.
    Hanning N; Edwinson AL; Ceuleers H; Peters SA; De Man JG; Hassett LC; De Winter BY; Grover M
    Therap Adv Gastroenterol; 2021; 14():1756284821993586. PubMed ID: 33717210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome.
    Zhao DY; Qi QQ; Long X; Li X; Chen FX; Yu YB; Zuo XL
    Physiol Int; 2019 Sep; 106(3):225-235. PubMed ID: 31560236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.